Table: Towa Pharmaceutical -2017/18 group results

TOWA PHARMACEUTICAL

14/05/2018 07:00

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             93.43           84.95          97.00        46.70    
                 (+10.0 pct)     (+3.5 pct)     (+3.8 pct)    (+4.5 pct) 
  Operating         11.64            6.87           9.70         4.00    
                 (+69.5 pct)     (-38.3 pct)    (-16.7 pct)  (-21.2 pct) 
  Recurring         11.72            7.42           9.60         3.95    
                 (+58.0 pct)     (-27.0 pct)    (-18.1 pct)  (-34.8 pct) 
  Net
  Net                6.50            5.58           7.00         2.90    
                 (+16.5 pct)     (-27.4 pct)    (+7.8 pct)   (-32.6 pct) 
  EPS            395.99 yen      339.96 yen     426.75 yen    176.80 yen 
  EPS Diluted    366.08 yen      314.23 yen                              
  Ann Div         95.00 yen       95.00 yen      95.00 yen               
  -Q2 Div         47.50 yen       47.50 yen      47.50 yen               
  -Q4 Div         47.50 yen       47.50 yen      47.50 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T